Terms: = Endocrine gland cancer AND Ki-67 AND Clinical Outcome
48 results:
1. Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
Haidar M; Al Mahmasani L; Chehade L; Elias C; El Jebai M; Temraz S; Charafeddine M; Al Darazi M; Shamseddine A
Nucl Med Commun; 2023 Jun; 44(6):471-479. PubMed ID: 36897058
[TBL] [Abstract] [Full Text] [Related]
2. TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor clinical outcome?
Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
[TBL] [Abstract] [Full Text] [Related]
3. [Multifactorial assessment of prognostic features of adrenocortical cancer].
Porubayeva EE; Pachuashvili NV; Urusova LS
Arkh Patol; 2022; 84(5):20-27. PubMed ID: 36178218
[TBL] [Abstract] [Full Text] [Related]
4. Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation.
Kachi K; Kato H; Naiki-Ito A; Komura M; Nagano-Matsuo A; Naitoh I; Hayashi K; Kataoka H; Inaguma S; Takahashi S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299067
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
[TBL] [Abstract] [Full Text] [Related]
6. Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.
Cavalcoli F; Pusceddu S; Zilli A; Tamagno G; Femia D; Prinzi N; Travers J; Consonni D; Ciafardini C; Conte D; Massironi S
Scand J Gastroenterol; 2019 Sep; 54(9):1111-1117. PubMed ID: 31454281
[No Abstract] [Full Text] [Related]
7. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract] [Full Text] [Related]
8. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
Gupta S; Zhang J; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
[TBL] [Abstract] [Full Text] [Related]
9. Non-functioning pituitary adenoma underwent surgery: A multicenter retrospective study over the last four decades (1977-2015).
Iglesias P; Arcano K; Triviño V; García-Sancho P; Díez JJ; Cordido F; Villabona C
Eur J Intern Med; 2017 Jun; 41():62-67. PubMed ID: 28389053
[TBL] [Abstract] [Full Text] [Related]
10. Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.
Lindgren A; Anttila M; Rautiainen S; Arponen O; Kivelä A; Mäkinen P; Härmä K; Hämäläinen K; Kosma VM; Ylä-Herttuala S; Vanninen R; Sallinen H
Eur Radiol; 2017 Sep; 27(9):4002-4012. PubMed ID: 28289938
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A; Rokutan H; Yachida S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of the methods for measuring the ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract] [Full Text] [Related]
14. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of ki-67 in solid pseudopapillary tumor of the pancreas: Huashan experience and systematic review of the literature.
Yang F; Yu X; Bao Y; Du Z; Jin C; Fu D
Surgery; 2016 Apr; 159(4):1023-31. PubMed ID: 26619927
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Three ki-67 Index Quantification Methods and clinical Significance in Pancreatic Neuroendocrine Tumors.
Kroneman TN; Voss JS; Lohse CM; Wu TT; Smyrk TC; Zhang L
Endocr Pathol; 2015 Sep; 26(3):255-62. PubMed ID: 26072124
[TBL] [Abstract] [Full Text] [Related]
17. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
[TBL] [Abstract] [Full Text] [Related]
18. Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.
Berntsson J; Lundgren S; Nodin B; Uhlén M; Gaber A; Jirström K
J Ovarian Res; 2014 Feb; 7():26. PubMed ID: 24568264
[TBL] [Abstract] [Full Text] [Related]
19. Expression of somatostatin receptors, angiogenesis and proliferation markers in pituitary adenomas: an immunohistochemical study with diagnostic and therapeutic implications.
Magagna-Poveda A; Leske H; Schmid C; Bernays R; Rushing EJ
Swiss Med Wkly; 2013; 143():w13895. PubMed ID: 24222652
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
[TBL] [Abstract] [Full Text] [Related]
[Next]